Search results
Results from the WOW.Com Content Network
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...
The big shareholder groups in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) have power over the company. Institutions will...
The analyst maintained the Buy rating on the stock. The analyst notes. On Friday, FDA's Oncologic Drugs Advisory Committee (ODAC) voted 16 to 0 that Y-mAbs Therapeutics Inc (NASDAQ: YMAB) did not ...
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced strategic ...
Stock name Symbol Country of origin M&T Bank Corporation: MTB: US M&T Bank Corporation MTB.PR: US M&T Bank Corporation MTB.PRC: US M&T Bank Corporation MTB.WS: US M/I Homes, Inc. MHO: US M/I Homes, Inc. MHO.PRA: US Macerich Co. MAC: US Mack Cali Realty Corporation CLI: US Macquarie Global Infrastructure Total Return Fund Inc. MGU: US
For premium support please call: 800-290-4726 more ways to reach us
Stock name Symbol Country of origin Yalla Group Limited YALA: United Arab Emirates: Yatsen Holding Limited YSG: China: Yelp Inc. YELP: United States: Yeti Holdings, Inc.
Stock name Symbol Country of origin Safe Bulkers Inc. SB: Greece: Salesforce.com: CRM: US Sally Beauty Holdings: SBH: US San Juan Basin Royalty Trust SJT